Skip Navigation

Dana-Farber Cancer Institute President and CEO recognized for excellence at AAMC annual meeting

  • Dana-Farber Cancer Institute President and CEO, Laurie H. Glimcher, MD, was honored by the AAMC (Association of American Medical Colleges) with the prestigious Award for Distinguished Research in the Biomedical Sciences at a special presentation on November 5, during Learn Serve Lead 2017: The AAMC Annual Meeting in Boston.

    The Award for Distinguished Research in the Biomedical Sciences honors outstanding medical research related to health and disease. The research recognized should have a positive impact on medicine and the health of patients and populations. The AAMC has awarded this prestigious research prize since 1947.

    In announcing the Award for Distinguished Research in the Biomedical Science, it was remarked that Glimcher developed a passion for discovery in childhood and she has noted that her career as a physician-scientist "chose me."

    Glimcher has made numerous discoveries that have advanced treatments for many diseases and chronic conditions, including cancer, asthma, and osteoporosis. She is widely considered to be the international authority on the development and activation of lymphocytes in the immune system. In addition to her pioneering research, Dr. Glimcher is a distinguished leader in academic medicine, previously serving as dean of Weill Cornell Medical College.

    Eight others were recognized for outstanding contributions to academic medicine at the ceremony. For more information about the 2017 honorees, visit www.aamc.org/initiatives/awards/2017-aamc-awards-recipients/.

Posted on November 06, 2017

  • Laurie H. Glimcher, MD
  • Media Contacts

    For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.

  • Laurie Glimcher, MD

    Laurie H. Glimcher, MD